A-share stocks buyback overview: 17 companies disclose buyback progress.

On May 13th, 17 companies announced updates on their stock buyback programs. Among them, 4 companies disclosed their stock buyback plans for the first time, 5 companies had their buyback plans approved by shareholders' meetings, 6 companies disclosed progress on their stock buyback implementation, and 2 companies have already completed their buyback programs. In terms of the initial disclosure of buyback plans, Haizheng Pharmaceutical, Guomai Culture, and Tianrun Industry have the highest planned buyback amounts, with plans to repurchase up to 100 million yuan, 100 million yuan, and 50 million yuan respectively. As for the buyback plans approved by shareholders' meetings, Delex Medical, Taihe New Materials, and Yidao Information have the highest planned buyback amounts, with plans to repurchase up to 100 million yuan, 49.3004 million yuan, and 23.589 million yuan respectively. In terms of the progress of buyback implementation, Guangda Special Materials, Oulaidi, and Zhejiang Pharmaceutical have the highest planned buyback amounts, with plans to repurchase 320 million yuan, 45.8177 million yuan, and 5.8959 million yuan respectively. And in terms of completed buybacks, Shunhao shares and Fangsheng Pharmaceutical have repurchased 99.9998 million yuan and 8325 yuan respectively.